Clinical effectiveness of semaglutide on weight loss, body composition, and muscle strength in Chinese adults.
塞麥格魯齊在中國成年人體重減輕、體組成和肌肉強度上的臨床效果。
Eur Rev Med Pharmacol Sci 2023-11-03
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism.
抗體阻斷活性素II型受體在 GLP-1 受體激動過程中保護骨骼肌肉質量並增進脂肪減少。
Mol Metab 2024-02-24
Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial.
liraglutide對超重或肥胖成年人大腿肌肉脂肪和肌肉組成的影響:來自一項隨機臨床試驗的結果。
J Cachexia Sarcopenia Muscle 2024-04-02
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials.
Semaglutide對瘦體重影響的系統性回顧:臨床試驗的見解。
Expert Opin Pharmacother 2024-05-04
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
胰高血糖素類體重減藥物治療:耐力運動是否能優化體組成的變化?
Diabetes Care 2024-04-30
Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies.
葡萄糖樣肽-1基因治療對瘦體重的影響及緩解策略。
Diabetes Obes Metab 2024-06-27